Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
McKesson
Boehringer Ingelheim
AstraZeneca
Baxter

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

SUPREP BOWEL PREP KIT Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Suprep Bowel Prep Kit patents expire, and what generic alternatives are available?

Suprep Bowel Prep Kit is a drug marketed by Braintree Labs and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has twenty-seven patent family members in thirteen countries.

The generic ingredient in SUPREP BOWEL PREP KIT is magnesium sulfate; potassium sulfate; sodium sulfate. There are one hundred and forty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the magnesium sulfate; potassium sulfate; sodium sulfate profile page.

Drug patent expirations by year for SUPREP BOWEL PREP KIT
Drug Prices for SUPREP BOWEL PREP KIT

See drug prices for SUPREP BOWEL PREP KIT

Recent Clinical Trials for SUPREP BOWEL PREP KIT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Pharmbio Korea Co., Ltd.Phase 4
Bo-In LeePhase 4
Mercy Medical Center, Des Moines, IowaN/A

See all SUPREP BOWEL PREP KIT clinical trials

Recent Litigation for SUPREP BOWEL PREP KIT

Identify potential future generic entrants

District Court Litigation
Case NameDate
BRAINTREE LABORATORIES, INC. v. HETERO LABS LIMITED2019-07-22
Braintree Laboratories, Inc. v. Lannett Company, Inc.2017-03-20
Braintree Laboratories, Inc. v. Novel Laboratories, Inc.2015-06-04

See all SUPREP BOWEL PREP KIT litigation

Synonyms for SUPREP BOWEL PREP KIT
1226807-19-7
DTXSID00153681
Magnesium sulfate anhydrous; potassium sulfate; sodium sulfate
Magnesium sulfate mixture with potassium sulfate and sodium sulfate
Suprep
Paragraph IV (Patent) Challenges for SUPREP BOWEL PREP KIT
Tradename Dosage Ingredient NDA Submissiondate
SUPREP BOWEL PREP KIT SOLUTION;ORAL magnesium sulfate; potassium sulfate; sodium sulfate 022372 2010-11-08

US Patents and Regulatory Information for SUPREP BOWEL PREP KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Braintree Labs SUPREP BOWEL PREP KIT magnesium sulfate; potassium sulfate; sodium sulfate SOLUTION;ORAL 022372-001 Aug 5, 2010 AA RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for SUPREP BOWEL PREP KIT

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1499331 13C0055 France   Start Trial PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
1499331 122014000007 Germany   Start Trial PRODUCT NAME: NATRIUMSULFAT, MAGNESIUMSULFAT UND KALIUMSULFAT; NAT. REGISTRATION NO/DATE: 86203.00.00 20130808; FIRST REGISTRATION: BELGIEN BE434323 20130220
1499331 C300615 Netherlands   Start Trial PRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220
1499331 SPC/GB13/034 United Kingdom   Start Trial PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313
1499331 2013C/049 Belgium   Start Trial DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CESSION
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Colorcon
McKesson
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.